Tetraethyl ranelate is a specialty chemical intermediate primarily used in the pharmaceutical industry for the synthesis of strontium ranelate, a medication indicated for the treatment of severe osteoporosis in postmenopausal women at high risk for fractures. As an ester derivative of ranelic acid, it plays a key role in the production of drugs that modulate bone remodeling by promoting bone formation and inhibiting bone resorption, thereby helping to maintain bone density and reduce fracture risk. It is not used directly as a therapeutic agent but supports the development of treatments for chronic bone diseases.